ClinTec International opens office in Istanbul

Published: 21-May-2013
Research & Development

Further expanding in the Middle East and North Africa


ClinTec International, a global contract clinical research organisation (CRO) with a presence in more than 40 countries, has opened an office in Istanbul, Turkey to further consolidate its presence in the Middle East and North Africa (MENA) region.

The new office joins a ClinTec network in Cairo, Egypt, Dubai Health Care City, UAE, and Beirut, Lebanon.

‘The launch of this new office in Turkey confirms ClinTec International’s reputation as a truly global provider of quality assured clinical research services,’ said ClinTec’s founder and CEO Rabinder Buttar.

‘It also reflects the growing significance of Turkey – and the wider MENA region – to the global clinical research market.’

  • Companies:
  • ClinTec International
See more

You may also like

Regulatory

Clintec secures Queen’s Award for Enterprise – International Trade

Read more
This is the second time the company has won the accolade, which recognises breadth and diversity of global capabilities

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  3. Steritas and argenx join forces to advance steroid-sparing therapeutic development With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid usage
  4. BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical characterisation
  5. Efficient PFAS-free degassing of aqueous solutions New silicone-based degassing chamber eliminates the risk of PFAS contamination

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Regulatory

Clintec secures Queen’s Award for Enterprise – International Trade

This is the second time the company has won the accolade, which recognises breadth and diversity of global capabilities
Research & Development

Clintec launches new brand and website

Clintec announces the launch of its new brand identity reflected in a newly created website, to mark their 20th year of global clinical research
Training & Education

ATC endorses Clintec International and Edinburgh Napier University Masters programme

Programme launched last year to support the development of clinical research staff throughout the world
Research & Development

ClinTec International starts operations in Malawi

Leading pharmaceutical company selects ClinTec as partner of choice in Africa and Asia
Research & Development

ClinTec expands into China, Singapore and Thailand

Increases presence in emerging markets
Research & Development

ClinTec International expands US capabilities

Appoints associate director of US Business Operations in New York
Training & Education

ClinTec opens training academy in Dubai

To focus on training clinical researchers in emerging markets
Subscribe now